Deletion polymorphism in the gene for angiotensin-converting enzyme is not a risk factor predisposing to abdominal aortic aneurysm

European Journal of Vascular and Endovascular Surgery

Volumn 18, Issue 2, 1999, Pages 158-161

  Hamano, K ^a   Ohishi, M ^b   Ueda, M ^c   Fujioka, K ^a   Katoh, T ^a   Zempo, N ^a   Fujimura, Y ^a   Okamura, A ^b   Rakugi, H ^b   Higaki, J ^b   Ogihara, T ^b   Esato, K ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Abdominal aortic aneurysm; Angiotensin converting enzyme; Gene; Polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DNA;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE DELETION; GENE FREQUENCY; GENOTYPE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RISK FACTOR;

EID: 0033179707     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejvs.1999.0873     Document Type: Article

References (32)

1. Kock AE, Haines GK, Rizzo RJ et al. Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response. Am J Path 1990; 137: 1199-1213.
2. McMillan WD, Tamarina NA, Cipollone M et al. Size matters. The relationship between MMP-9 expression and aortic diameter. Circulation 1997; 96: 2228-2232.
3. Reed D, Reed C, Stemmermann G, Hayashi T. Are aortic aneurysms caused by atherosclerosis? Circulation 1992; 85: 205-211.
4. MacSweeney STR, Ellis M, Worrell PC, Greenhalgh RM, Powell JT. Smoking and growth rate of small abdominal aortic aneurysms. Lancet 1994; 344: 651-652.
5. LaMorte WW, Scott TE, Menzoian JO. Relationship of cardiovascular risk factors to racial differences in femoral bypass surgery and abdominal aortic aneurysmectomy in Massachusetts. Ann N Y Acad Sci 1996; 800: 25-35.
6. Lederle FA, Johnson GR, Wilson SE et al. Prevalence and associations of abdominal aortic aneurysm detected through screening. Ann Intern Med 1997; 126: 441-449.
7. Cambien F, Poirier O, Lecerf L et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-644.
8. Agerholm-Larsen B, Nordestgaard BG, Steffensen R et al. ACE gene polymorphism: Ischemic heart disease and longevity in 10150 individuals. Circulation 1997; 95: 2358-2367.
9. Kamitani A, Rakugi H, Higaki J et al. Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. Hypertension 1995; 25: 950-953.
10. Ohishi M, Fujii K, Minamino T et al. A potent genetic risk factor for restenosis. Nature Genet 1993; 5: 324-325.
11. Schunkert H, Hense HW, Holmer SR et al. Deletion polymorphism in the angiotensin converting enzyme gene is a strong risk factor for left ventricular hypertrophy in humans. N Engl J Med 1994; 330: 1634-1638.
12. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M. DD genotype of the angiotensin-converting-enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994; 90: 2622-2628.
13. Missouris CG, Barley J, Jeffery S et al. Genetic risk for renal artery stenosis: Association with deletion polymorphism in angiotensin 1-converting enzyme gene. Kidney Int 1996; 49: 534-537.
14. Markus HS, Barley J, Lunt R et al. Angiotensin-converting enzyme gene deletion polymorphism: A new risk factor for lacunar stroke but not carotid atheroma. Stroke 1995; 126: 1329-1333.
15. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992; 20: 1433.
16. Rigat B, Hubert C, Alhenc-Gelas F et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346.
17. Tiret L, Rigat B, Visvikis S et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992; 51: 197-205.
18. Lindpaintner K, Pfeffer MA, Kreutz R et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995; 332: 706-711.
19. Danser AHJ, Schalekamp MADH, Bax WA et al. Angiotensin-converting enzyme in the human heart: Effect of the deletion/insertion polymorphism. Circulation 1995; 92: 1387-1388.
20. Dzau VJ. The role of mechanical and humoral factors in growth regulation of vascular smooth muscle and cardiac myocytes. Curr Opin Nephrol Hypertens 1993; 2: 27-32.
21. Mii S, Ware JA, Mallette SA, Kent KC. Effect of angiotensin II on human vascular smooth muscle cell growth. J Surg Res 1994; 57: 174-178.
22. Makita S, Nakamura M, Yoshida H, Hiramori K. Effect of angiotensin II receptor blocker on angiotensin II stimulated DNA synthesis of cultured human aortic smooth muscle cells. Life Sci 1995; 56: 383-388.
23. Ohishi M, Ueda M, Rakugi H et al. Enhanced expression of angiotensin-converting enzyme is associated with progression of coronary atherosclerosis in humans. J Hypertens 1997; 15: 1295-1302.
24. Ohishi M, Ueda M, Rakugi H et al. Upregulation of angiotensin-converting enzyme during the healing process after injury at the site of percutaneous transluminal coronary angioplasty in humans. Circulation 1997; 96: 3328-3337.
25. Glagov S. Morphology of collagen and elastin fibers in atherosclerotic lesions. Adv Exp Med Biol 1975; 82: 767-773.
26. Sumner DS, Hokansen DE, Strandness DE. Stress-strain characteristics and collagen-elastin content of abdominal aortic aneurysms. Surg Gynecol Obstet 1970; 130: 459-466.
27. Campa JS, Greenhalgh RM, Powell JT. Elastin degradation in abdominal aortic aneurysms. Atherosclerosis 1987; 65: 13-21.
28. Munro JM, Van der Walt JD, Munro CS, Chalmers JAC, Cox EL. An immunohistochemical analysis of human aortic fatty streaks. Hum Pathol 1987; 18: 375-380.
29. Rizzo RJ, McCarthy WJ, Dixit SN et al. Collagen types and matrix protein content in human abdominal aortic aneurysms. J Vasc Surg 1989; 10: 365-373.
30. Powell J, Greenhalgh RM. Cellular, enzymatic, and genetic factors in the pathogenesis of abdominal aortic aneurysms. J Vasc Surg 1989; 9: 297-304.
31. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F. Angiotensin I-converting enzyme in human circulating mononuclear cells: Genetic polymorphism of expression in T-lymphocytes. Biochem J 1993; 290: 33-40.
32. Lindapaintner K, Lee M, Larson MG et al. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med 1996; 334: 1023-1028.